Recursion Pharmaceuticals, Inc. acquired substantially all the assets of Vium, Inc. on July 28, 2020. As part of the transaction, the team at Vium in-house will be brought to Recursion. Recursion Pharmaceuticals, Inc. completed the acquisition of substantially all the assets of Vium, Inc. for $2.6 million on July 28, 2020. The consideration was paid for $2.6 million in cash.